Status:
COMPLETED
Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients
Lead Sponsor:
Maastricht Radiation Oncology
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
In a retrospective study the investigators defined quantitative action levels based on dose and volume measures for adaptive radiation therapy in breast cancer patients (Zegers et al. Acta Oncol 2017)...
Detailed Description
During radiotherapy, changes in patient anatomy or positioning can result into differences in dose deposition, which is the main factor influencing tumor control or side-effects. Dose-guided radiation...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Breast cancer patients
- Planned for external beam radiation treatment.
- Whole breast irradiation or Simultaneous integrated boost
Exclusion
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 20 2018
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT03385031
Start Date
January 1 2018
End Date
August 20 2018
Last Update
March 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht Radiation Oncology
Maastricht, Netherlands, 6202 AZ